Cancer, Advanced Not Yet Recruiting Phase 2 Trials for Osimertinib (DB09330)

Also known as: Advanced Cancer / Cancer / Neoplasm malignant / Malignant neoplasm NOS / Cancer NOS / Malignant tumor / Malignant tumour / Cancer (NOS) / Malignant neoplasm without specification of site

IndicationStatusPhase
DBCOND0041606 (Cancer, Advanced)Not Yet Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs